Transdel Pharmaceuticals Inc. (TDLP.OB) Completes $4 Million Private Placement, Looking for Marketing/Distribution Partner
When it comes to investing in pharmaceutical companies, an investor needs to be aware of the company’s pipeline. How close a product is to final approval, and what is coming along behind it, are the leading indicators of the company's potential. Problems can crop up at any time to sidetrack a new drug in the approvals process, but as these drugs get closer to the end of Phase III FDA approvals, many companies start to circle for their piece of the pie. Transdel Pharmaceuticals Inc., a specialty developer of topical pharmaceuticals, works to discover and commercialize products oriented toward topical…